Sommario

• • ·Table of Contents

    Pagina :A1

    
• • ·Editorial Board

    Pagina :A4

    

• Editorial

  • ·The new era of clinical research: Using data for multiple purposes

    Pagina :133-134

    Robert M. Califf

    

• Results of Expert Meetings

  • ·Independent data monitoring committees: Preparing a path for the future

    Pagina :135

    Connie N. Hess, Matthew T. Roe, C. Michael Gibson, Robert J. Temple, Michael J. Pencina, Deborah A. Zarin, Kevin J. Anstrom, John H. Alexander, Rachel E. Sherman, Fred T. Fiedorek, Kenneth W. Mahaffey, Kerry L. Lee, Shein-Chung Chow, Paul W. Armstrong, Robert M. Califf

    Riassunto Riassunto Mappa Mappa  
  • ·Designing effective drug and device development programs for hospitalized heart failure: A proposal for pretrial registries

    Pagina :142-149

    Stephen J. Greene, Ami N. Shah, Javed Butler, Andrew P. Ambrosy, Stefan D. Anker, Ovidiu Chioncel, Sean P. Collins, Wilfried Dinh, Preston M. Dunnmon, Gregg C. Fonarow, Carolyn S.P. Lam, Robert J. Mentz, Burkert Pieske, Lothar Roessig, Giuseppe M.C. Rosano, Naoki Sato, Muthiah Vaduganathan, Mihai Gheorghiade

    Riassunto Riassunto Mappa Mappa  

• Curriculum in Cardiology

  • ·A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement

    Pagina :150

    Shin-Jae Kim, Zainab Samad, Gerald S. Bloomfield, Pamela S. Douglas

    Riassunto Riassunto Mappa Mappa  

• Trial Design

  • ·Outcomes registry for better informed treatment of atrial fibrillation II: Rationale and design of the ORBIT-AF II registry

    Pagina :160-167

    Benjamin A. Steinberg, Rosalia G. Blanco, Donna Ollis, Sunghee Kim, DaJuanicia N. Holmes, Peter R. Kowey, Gregg C. Fonarow, Jack Ansell, Bernard Gersh, Alan S. Go, Elaine Hylek, Kenneth W. Mahaffey, Laine Thomas, Paul Chang, Eric D. Peterson, Jonathan P. Piccini, ORBIT-AF Steering Committee Investigators

    Riassunto Riassunto Mappa Mappa  
  • ·Rationale and design of the AngeLmed for Early Recognition and Treatment of STEMI trial: A randomized, prospective clinical investigation

    Pagina :168-174

    Michael C. Gibson, Mitchell Krucoff, David Fischell, Tim A. Fischell, David Keenan, Cassandra Abueg, Charmaine Patel, David Holmes

    Riassunto Riassunto Mappa Mappa
  • ·Does optical coherence tomography optimize results of stenting? Rationale and study design

    Pagina :175

    Nicolas Meneveau, Fiona Ecarnot, Geraud Souteyrand, Pascal Motreff, Christophe Caussin, Eric Van Belle, Patrick Ohlmann, Olivier Morel, Alain Grentzinger, Michael Angioi, Romain Chopard, François Schiele

    Riassunto Riassunto Mappa Mappa

• Clinical Investigations

  • ·Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non–ST-segment elevation acute coronary syndromes

    Pagina :182

    Rajendra H. Mehta, Cynthia M. Westerhout, Yinggan Zheng, Robert P. Giugliano, Kurt Huber, Dorairaj Prabhakaran, Robert A. Harrington, Kristin L. Newby, Paul W. Armstrong, EARLY ACS Investigators

    Riassunto Riassunto Mappa Mappa  
  • ·Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non–ST-segment elevation acute coronary syndrome

    Pagina :189

    Amit N. Vora, Michael Chenier, Phillip J. Schulte, Shaun Goodman, Eric D. Peterson, Karen Pieper, Marc E. Jolicoeur, Kenneth W. Mahaffey, Harvey White, Tracy Y. Wang

    Riassunto Riassunto Mappa Mappa  
  • ·Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial

    Pagina :197

    Erik Kjøller, Jørgen Hilden, Per Winkel, Søren Galatius, Niels Jørgen Frandsen, Gorm B. Jensen, Jørgen Fischer Hansen, Jens Kastrup, Christian M. Jespersen, Per Hildebrandt, Hans Jørn Kolmos, Christian Gluud, CLARICOR Trial Group

    Riassunto Riassunto Mappa Mappa  
  • ·Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population

    Pagina :205

    Michael A. Blazing, Robert P. Giugliano, Christopher P. Cannon, Thomas A. Musliner, Andrew M. Tershakovec, Jennifer A. White, Craig Reist, Amy McCagg, Eugene Braunwald, Robert M. Califf

    Riassunto Riassunto Mappa Mappa  
  • ·Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov registry

    Pagina :213

    Sabrina Bernardez-Pereira, Renato D. Lopes, Maria Julia Machline Carrion, Eliana Vieira Santucci, Rafael Marques Soares, Matheus de Oliveira Abreu, Ligia Nasi Laranjeira, Dimas T. Ikeoka, Ana Denise Zazula, Frederico Rafael Moreira, Alexandre Biasi Cavalcanti, Evandro Tinoco Mesquita, Eric D. Peterson, Robert M. Califf, Otavio Berwanger, Methodological Evaluation of clinical TriAls (META) Study Group

    Riassunto Riassunto Mappa Mappa  
  • ·Is there a role for diastolic function assessment in era of delayed enhancement cardiac magnetic resonance imaging? : A multimodality imaging study in patients with advanced ischemic cardiomyopathy

    Pagina :220

    João L. Cavalcante, Thomas H. Marwick, Rory Hachamovitch, Zoran B. Popovic, Nael Aldweib, Randall C. Starling, Milind Y. Desai, Scott D. Flamm, Deborah H. Kwon

    Riassunto Riassunto Mappa Mappa  
  • ·Role of simultaneous carotid ultrasound in patients undergoing stress echocardiography for assessment of chest pain with no previous history of coronary artery disease

    Pagina :229-236

    Shahram Ahmadvazir, Konstantinos Zacharias, Benoy N. Shah, Jatinder S. Pabla, Roxy Senior

    Riassunto Riassunto Mappa Mappa  

• Letters to the Editor

  • ·Interarm blood pressure differences should also be recorded

    Pagina :e7

    Oscar M.P. Jolobe

    
  • ·The EARNEST Study: Interarm blood pressure differences should also be recorded

    Pagina :e9

    William E. Moody, Charles J. Ferro, Jonathan N. Townend, On behalf of the EARNEST Study Investigators

    
  • ·Pre-percutaneous coronary intervention statin therapy: Is it necessary?

    Pagina :e11

    Josef Veselka

    
  • ·Reply to: Prepercutaneous coronary interventions statin therapy: Is it necessary?

    Pagina :e13

    Mohamad Kenaan, Hitinder S. Gurm